指南与共识神经外科与老年麻醉心胸血管麻醉

围术期脑氧监测共识:脑近红外光谱在围术期结局中的作用

American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on the Role of Neuromonitoring in Perioperative Outcomes: Cerebral Near-Infrared Spectroscopy.
指南 / 共识 · Anesth Analg · 2020-01-01

该共识由国际多学科专家团队基于GRADE系统评估脑氧饱和度监测文献,提出9条推荐:强调以诱导前基线解读脑氧值、注意生理变量影响、不同品牌设备不可互换;对心脏手术可用脑氧识别高危患者及指导灌注异常管理,但证据不足以推荐用于降低死亡率或非心脏手术。

要点

  • 脑氧监测应以诱导前基线为参照解读数值。
  • 不同品牌脑氧仪不可互换比较,需谨慎。
  • 心脏手术可用脑氧识别高危和指导灌注管理。

核心结论

  • 围术期脑氧监测应基于诱导前基线及生理变量解读,不同品牌设备不可互换。
  • 心脏手术中脑氧可用于识别高危患者和指导急性脑灌注异常管理。
  • 证据不足以推荐脑氧用于降低心脏手术死亡率或改善非心脏手术结局。

研究设计与样本

  • 第六届围术期质量倡议(POQI-6)共识会议召集麻醉科、外科和重症监护多学科国际专家团队。
  • 系统调查脑氧文献,按GRADE标准评估证据并形成共识推荐。

主要发现

  • 现代脑氧仪测量特定光学场内动脉、毛细血管和静脉血的血红蛋白饱和度,并非组织氧合本身。
  • 多种脑氧仪存在技术差异,不可互换使用。
  • 脑氧测量机制和意义可能未被许多执业医生广泛理解。
  • 缺乏高质量证据支持临床决策以减少术后神经认知并发症。

关键数值与推荐

  • 推荐1:以诱导前基线值解读围术期脑氧测量。
  • 推荐2:结合影响脑氧的生理变量解读测量值。
  • 推荐3:比较不同制造商脑氧值时需谨慎。
  • 推荐4:术前脑氧用于识别心脏手术后不良结局风险增加的患者。
  • 推荐5:术中脑氧以诱导前基线为索引识别心脏手术后不良结局风险增加的患者。

临床怎么用

  • 临床解读脑氧值时应以诱导前基线为参照。
  • 使用脑氧监测时需考虑影响读数的生理变量。
  • 避免直接比较不同品牌脑氧仪的数值。
  • 心脏手术中可利用脑氧识别高危患者并指导灌注异常管理。
  • 不推荐将脑氧作为降低死亡率或非心脏手术结局的常规手段。

局限性

  • 缺乏高质量证据支持脑氧监测减少术后神经认知并发症。
  • 证据不足以推荐脑氧降低心脏手术死亡率或器官特异性并发症。
  • 证据不足以推荐脑氧改善非心脏手术结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Some neurological complications following surgery have been related to a mismatch in cerebral oxygen supply and demand that may either lead to more subtle changes of brain function or overt complications like stroke or coma. Discovery of a perioperative neurological complication may be outside the treatment window, thereby making prevention an important focus. Early commercial devices used differential spectroscopy to measure relative changes from baseline of 2 chromophores: oxy- and deoxyhemoglobin. It was the introduction of spatially resolved spectroscopy techniques that allowed near-infrared spectroscopy (NIRS)-based cerebral oximetry as we know it today. Modern cerebral oximeters measure the hemoglobin saturation of blood in a specific "optical field" containing arterial, capillary, and venous blood, not tissue oxygenation itself. Multiple cerebral oximeters are commercially available, all of which have technical differences that make them noninterchangeable. The mechanism and meaning of these measurements are likely not widely understood by many practicing physicians. Additionally, as with many clinically used monitors, there is a lack of high-quality evidence on which clinicians can base decisions in their effort to use cerebral oximetry to reduce neurocognitive complications after surgery. Therefore, the Sixth Perioperative Quality Initiative (POQI-6) consensus conference brought together an international team of multidisciplinary experts including anesthesiologists, surgeons, and critical care physicians to objectively survey the literature on cerebral oximetry and provide consensus, evidence-based recommendations for its use in accordance with the GRading of Recommendations, Assessment, Development and Evaluation (GRADE) criteria for evaluating biomedical literature. The group produced the following consensus recommendations: (1) interpreting perioperative cerebral oximetry measurements in the context of a preinduction baseline value; (2) interpreting perioperative cerebral oximetry measurements in the context of the physiologic variables that affect them; (3) using caution in comparing cerebral oximetry values between different manufacturers; (4) using preoperative cerebral oximetry to identify patients at increased risk of adverse outcomes after cardiac surgery; (5) using intraoperative cerebral oximetry indexed to preinduction baseline to identify patients at increased risk of adverse outcomes after cardiac surgery; (6) using cerebral oximetry to identify and guide management of acute cerebral malperfusion during cardiac surgery; (7) using an intraoperative cerebral oximetry-guided interventional algorithm to reduce intensive care unit (ICU) length of stay after cardiac surgery. Additionally, there was agreement that (8) there is insufficient evidence to recommend using intraoperative cerebral oximetry to reduce mortality or organ-specific morbidity after cardiac surgery; (9) there is insufficient evidence to recommend using intraoperative cerebral oximetry to improve outcomes after noncardiac surgery.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Thiele RH, Shaw AD, Bartels K, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on the Role of Neuromonitoring in Perioperative Outcomes: Cerebral Near-Infrared Spectroscopy. Anesth Analg. 2020. PMID: 33079868. doi:10.1213/ANE.0000000000005081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。